For example, the synergy between GLP-1 and continuous glucose monitoring (CGM) devices is expected to significantly improve diabetes management and disease prevention
More recently, studies with larger sample sizes and superior study design have demonstrated a significantly increased risk of ASCVD associated with G6PD-d
I dont think it is fair to the patient with obesity
The FDA-approved, branded versions of GLP-1 products were so popular that the brand manufacturers were not able to keep up with demand, prompting the FDA to declare a shortage for each of the semaglutide and tirzepatide products over the course of 2022
In fact, studies show that people who experience fatigue on Ozempic often have more GI symptoms, too
Ideally, this specialist works within a multidisciplinary practice and is experienced in all available interventions, allowing patients to receive guidance on the full spectrum of options tailored to their unique needs